Prolonged injury and altered lung function after ozone inhalation in mice with chronic lung inflammation

Angela M Groves1, Andrew J Gow, Christopher B Massa

  • 1Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.

Insights

Loss of Surfactant protein-D (Sftpd) exacerbates ozone-induced lung injury and inflammation. Sftpd-deficient mice show prolonged injury, oxidative stress, and altered lung mechanics after ozone exposure.

Area of Science:

  • Pulmonary immunology
  • Environmental toxicology
  • Respiratory physiology

Background:

  • Surfactant protein-D (Sftpd) is crucial for regulating macrophage inflammatory responses in the lungs.
  • Chronic inflammation due to Sftpd deficiency can impact lung injury persistence and function.

Purpose of the Study:

  • To investigate the effects of Sftpd loss on ozone-induced lung injury, macrophage activation, and lung function.
  • To analyze the role of Sftpd in mitigating the consequences of environmental pollutant exposure.

Main Methods:

  • Wild-type and Sftpd-deficient mice were exposed to air or ozone.
  • Bronchoalveolar lavage (BAL) fluid and tissue were collected 72 hours post-exposure.
  • Lung injury, oxidative stress markers, macrophage activation, and lung mechanics were assessed.

Main Results:

  • Sftpd-deficient mice exhibited prolonged lung injury, increased BAL protein, and elevated nitrogen oxides after ozone exposure.
  • Ozone exposure led to increased, activated macrophages in Sftpd-deficient mice, evidenced by chemotactic activity and iNOS expression.
  • Lung function alterations were more extensive in Sftpd-deficient mice, affecting both central airways and parenchyma, unlike wild-type mice.

Conclusions:

  • Sftpd deficiency is linked to prolonged lung injury, oxidative stress, and heightened macrophage responses to ozone.
  • The absence of Sftpd results in more severe functional lung changes, including loss of parenchymal integrity, following ozone inhalation.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...